Let's communicate with patients like it’s 2018 Dupixent for moderate-to-severe atopic dermatitis in adultsThe drug is the first biologic therapy for eczema to be approved in Canada Bitcoin: Does it belong in your investment portfolio? How does paperwork drive physician burnout? Foquest: new once-daily stimulant designed for adults with ADHD Controlled-release methylphenidate product has one-hour onset and 16-hour duration of action The silent health crisis Belbuca: new buccal opioid analgesic now available in Canada Provides transmucosal delivery of buprenorphine for twice-daily treatment of chronic pain Federal centre flags signs of cash linked to fentanyl scourge in new alert Does 'ghosting' undermine healthcare collaboration? Brain researchers explore role of white matter disease in dementia First Previous 356 357 358 359 360 Next Last
